-
Rybakina downs Swiatek to reach WTA Finals last four
-
Ex-France international Ben Yedder to stand trial on rape charges
-
Djokovic confirmed for ATP Finals, says Italian federation boss
-
Trent should be remembered for 'great' Liverpool moments, says Slot
-
Stock markets diverge despite boost from AI deals
-
Prince William awed by Rio on climate-focused trip to Brazil
-
Violence in Sudan's El-Fasher could be war crimes, says top court
-
Rybakina downs Swiatek in WTA Finals
-
Turkey, Muslim allies say Palestinian self-rule key to Gaza future
-
Tens of thousands shelter as typhoon slams into Philippines
-
Stock markets rise as tech sector buoyed by fresh AI deal
-
Vitinha says PSG-Bayern Champions League clash will show who's 'best'
-
Arsenal: The unstoppable Premier League force?
-
Denmark inaugurates rare low-carbon hydrogen plant
-
Springboks back Ntlabakanye call-up despite doping probe
-
German plans to lower industrial power costs from January
-
Christian, Muslim Nigerians push back on threatened US strikes
-
Nigeria's Rivers United paired with African champions Pyramids
-
India women cricketers hail new era but challenges remain
-
'Heroic' worker praised as man charged over UK train stabbings
-
Bangladesh ex-PM Zia to contest elections: party
-
Tanzania president sworn in as opposition says hundreds killed in protests
-
India announces $5.75 million reward for women cricket World Cup winners
-
Stock markets rise on AI optimism
-
Spain regional leader resigns, a year after deadly floods
-
Video game creators fear AI could grab the controller
-
France threatens Shein ban if 'childlike' sex dolls reappear
-
International cricket returns to Faisalabad with Pakistan-South Africa ODIs
-
Afghan govt says quake kills 20, injures over 500
-
'We're all too rich,' says photo legend Martin Parr
-
Tanzania president inaugurated as opposition says hundreds dead
-
Shafali Verma: India's World Cup hero who disguised herself as boy
-
Most equity markets rise on lingering trader optimism
-
Asian markets rise on lingering trader optimism
-
Afghanistan quake kills 20, injures over 300: health ministry
-
India hails maiden women's World Cup cricket title as game-changer
-
As clock ticks down, Greece tries to clean up its act on waste
-
Local fabrics, fibres shine at eco-centred Lagos Fashion Week
-
Spalletti bidding to revive Juve and reputation ahead of Sporting visit in Champions League
-
Tanzania president to be inaugurated as opposition says hundreds dead
-
Bouanga brace as LAFC beats Austin 4-1 to advance in MLS Cup playoffs
-
'Golden age': Japan hails Yamamoto, Ohtani after Dodgers triumph
-
Thunder roll over Pelicans to remain NBA's lone unbeaten team
-
Hong Kong legislature now an 'echo chamber', four years after shake-up
-
Most Asian markets rise on lingering trader optimism
-
Andrew to lose his last military rank: defence minister
-
Trump's global tariffs to face challenge before Supreme Court
-
Barnstorming Bayern face acid test at reigning champions PSG
-
Alonso shaping new Real Madrid on Liverpool return
-
Half Yours favourite at Australia's 'race that stops a nation'
| CMSC | -0.38% | 23.66 | $ | |
| RIO | -1.95% | 70.37 | $ | |
| BCC | -3.83% | 67.89 | $ | |
| BCE | -0.99% | 22.635 | $ | |
| SCS | -0.03% | 15.955 | $ | |
| BP | -0.14% | 35.08 | $ | |
| GSK | -0.95% | 46.42 | $ | |
| NGG | -0.41% | 74.94 | $ | |
| BTI | 2.55% | 52.53 | $ | |
| CMSD | -0.33% | 23.91 | $ | |
| RBGPF | -3.95% | 76 | $ | |
| RYCEF | 1.24% | 15.34 | $ | |
| JRI | -0.43% | 13.84 | $ | |
| AZN | -0.98% | 81.6 | $ | |
| VOD | -5.47% | 11.425 | $ | |
| RELX | -0.16% | 44.17 | $ |
New 'highly virulent' HIV strain discovered in the Netherlands
Oxford researchers announced Thursday the discovery of a highly virulent strain of HIV that has been lurking in the Netherlands for decades, but because of the effectiveness of modern treatments, is "no cause for alarm."
Their analysis, published Thursday in the journal "Science," showed that patients infected with what they call the "VB variant" had 3.5 to 5.5 times higher levels of the virus in their blood than those infected with other variants, as well as a more rapidly fading immune system.
However, the study also found that after starting treatment, individuals with the VB variant had similar immune system recovery and survival to individuals with other HIV variants.
"There's no cause for alarm with this new viral variant," said Oxford epidemiologist Chris Wymant, the lead author on the paper, in an interview with AFP.
The variant likely arose in the late 1980s and early 1990s in the Netherlands, according to the researchers, but began to decline around 2010.
Since modern interventions still seem to work on the variant, the research team believes that widespread HIV treatment in the Netherlands did not contribute to the virus's evolution, and that early detection and treatment are paramount.
"Our findings emphasize the importance of World Health Organization guidance that individuals at risk of acquiring HIV have access to regular testing to allow early diagnosis, followed by immediate treatment," said co-author Christophe Fraser, also an Oxford researcher, in a press release announcing the findings.
The work also supports the theory that viruses can evolve to become more virulent, a widely-hypothesized idea for which few real-world examples have been found.
The Delta variant of the novel coronavirus was another recent example.
The discovery of the HIV variant should therefore "be a warning that we should never be overconfident about saying viruses will just evolve to become milder," said Wymant to AFP.
In total, the team found 109 people infected with the VB variant, with only four living outside the Netherlands, but still in western Europe.
- 500 mutations -
The HIV virus is constantly evolving, so much so that each person infected has a slightly different version.
The VB variant, however, was found to have over 500 mutations.
"Finding a new variant is normal, but finding a new variant with unusual properties is not -- especially one with increased virulence," Wyman explained.
The research team first identified the VB variant in 17 HIV positive individuals by parsing a broad data set from the BEEHIVE project, a data collection and analysis initiative in Europe and Uganda.
Because 15 of the 17 were from the Netherlands, they further studied data from 6,700 HIV-positive Dutch individuals, identifying 92 others.
The earliest appearance of the VB variant in their data was found in someone diagnosed in 1992 who had an early version of the variant, and the most recent in 2014.
Other researchers have since found other individuals with the variant diagnosed after 2014.
Doctors usually measure HIV's deterioration of the immune system by monitoring the decline of CD4 T-cells, which are targeted by the HIV virus and pivotal for protecting the body against infections.
In patients infected with the VB variant, CD4 decline occurred twice as fast compared to other variants, "placing them at risk of developing AIDS much more rapidly," the researchers said.
In addition to its increased impact on the immune system, the team also found the VB variant to be more highly transmissible.
They came to that conclusion after comparing the different versions of the VB variant drawn from infected patients.
The fact that they were so similar suggests that the virus passed rapidly to someone else before it could accumulate many mutations.
- 'Critical' to diagnose and treat early -
"Because the VB variant causes a more rapid decline in immune system strength, this makes it critical that individuals are diagnosed early and start treatment as soon as possible," the press statement noted.
"This limits the amount of time HIV can damage an individual's immune system and jeopardize their health," added Fraser.
Fraser is also the principal investigator of the BEEHIVE project, which was launched in 2014 to gather data on how mutations in the HIV virus can lead to varying degrees of severity among patients.
Those differences have previously been thought to mostly relate to the strength of individuals' own immune systems.
The researchers said they could not identify which genetic mutation in the VB variant caused its virulence, but they hope future studies will be able to.
B.Finley--AMWN